Rank 31 • MedTech & Devices
Procept BioRobotics
Develops the Aquabeam Robotic System for minimally invasive treatment of benign prostatic hyperplasia.
Visit website- Signal Score
- 89.6
- Total raised
- $300M
- Stage
- Public
- Founded
- 2007
- Headquarters
- San Jose, USA
- Region
- North America
Their signal
By offering highly automated, heat-free tissue ablation, its platform is quickly becoming the gold standard of care for urology departments across the United States and Europe.
Signal Score 89.6editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in MedTech & Devices
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.